Grants for Small businesses - Federal

This funding opportunity supports collaborative research projects that utilize existing biosamples and data from clinical studies on type 1 diabetes to enhance understanding of the disease and promote diverse research perspectives.

This funding opportunity supports innovative research into the biological mechanisms of complex brain disorders, targeting early-stage projects that explore genetic and environmental risk factors affecting conditions like schizophrenia and depression.

This funding opportunity supports researchers investigating the biological and social factors behind neuropsychiatric symptoms in Alzheimer's disease to improve patient care and identify new treatment targets.

This funding opportunity provides financial support to a wide range of organizations to develop infrastructure that enhances research in population dynamics, focusing on demographic, economic, social, and health-related studies.

This funding opportunity supports the development of noninvasive diagnostic tools that utilize electronic nose technology to detect disease biomarkers, encouraging participation from a wide range of organizations, including governments, educational institutions, and small businesses.

This funding opportunity is designed to equip researchers focused on substance use disorders with the entrepreneurial skills needed to turn their scientific discoveries into impactful products that benefit affected communities.

This grant provides funding for researchers to develop and test innovative devices that diagnose and treat conditions affecting the nervous system in humans.

This funding opportunity supports innovative research to uncover the biological mechanisms of bladder cancer, inviting diverse teams to explore areas such as tumor development, microenvironment, and health disparities.

This funding opportunity supports research projects that evaluate potential human carcinogens, providing essential assessments to inform cancer prevention and public health policies.

This funding opportunity provides financial support for research projects that investigate new health conditions related to the 9/11 attacks, focusing on vulnerable populations affected by the disaster.

This funding opportunity supports organizations in conducting multi-site clinical trials focused on innovative treatments and interventions for Alzheimer's Disease and related dementias.

This grant encourages researchers and organizations to create and share high-quality datasets that improve the prediction of toxicity in oligonucleotide therapeutics, particularly using human-based testing methods.

This funding opportunity supports postdoctoral researchers in biomedical sciences as they transition to independent faculty positions, providing financial resources for their research on infectious, allergic, and immunologic diseases.

This grant provides funding for researchers and organizations to develop and advance nanotechnology-based cancer treatments and diagnostics, focusing on preclinical studies that align with clinical objectives.

This funding opportunity supports early-stage and established researchers new to Alzheimer's disease and related dementias, providing up to $100,000 for innovative pilot studies that address critical challenges in prevention, diagnosis, treatment, and care.

This funding opportunity supports research centers that will develop predictive models to understand how genetic variations impact genome function, contributing to a collaborative network aimed at advancing human health through genomic research.

This funding opportunity supports researchers in analyzing existing health datasets to uncover insights related to heart, lung, and blood diseases, as well as sleep disorders, with a focus on improving public health outcomes.

This funding opportunity supports research projects that analyze data related to childhood cancers and birth defects, aiming to improve diagnostics and therapies through innovative genomic studies.

This funding opportunity supports research institutions and organizations in developing standardized practices for handling biospecimens to improve the reliability of clinical biomarker assays used in cancer diagnosis and treatment.

This funding opportunity supports individuals transitioning from residency to independent research roles in cardiovascular, lung, blood diseases, and sleep disorders, specifically targeting those who have completed an R38 program.